Literature DB >> 22424284

Patients with coronary artery disease unsuitable for revascularization: definition, general principles, and a classification.

E Marc Jolicoeur1, Raymond Cartier, Tim D Henry, Greg W Barsness, Martial G Bourassa, Micheal McGillion, Philippe L L'Allier.   

Abstract

In the present report, we review the phenotypes of coronary artery disease (CAD) patients unsuitable for revascularization procedures. We then analyze these phenotypes and propose a simple angiographic-based classification for patients with CAD unsuitable for revascularization. Under this classification, the following four distinct angiographic phenotypes are proposed: (1) suspected cardiac syndrome X; (2) limited territory at risk; (3) diffuse thread-like coronary atherosclerosis; and (4) end-stage CAD. It is hoped that such a classification system, as well as the general principles described in this report, will help to standardize the collection of epidemiological data on patients with refractory angina (RFA) and advanced CAD. It is also hoped that this system will be useful to extend the principles of clinical equipoise to the development of clinical trials of innovative therapies or devices for the treatment of RFA. Finally, we anticipate that the elaboration of this system, the first of its type in the literature, will stimulate discussion of what we feel to be a subject that has received insufficient attention in the literature, and ultimately to improved management of a challenging patient population.
Copyright © 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22424284     DOI: 10.1016/j.cjca.2011.10.015

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  12 in total

Review 1.  Transmyocardial laser revascularization versus medical therapy for refractory angina.

Authors:  Eduardo Briones; Juan Ramon Lacalle; Ignacio Marin-Leon; José-Ramón Rueda
Journal:  Cochrane Database Syst Rev       Date:  2015-02-27

2.  Relation of Previous Coronary Artery Bypass Grafting and/or Percutaneous Coronary Intervention to Perioperative Cardiovascular Outcomes in Patients Who Underwent Noncardiac Surgery.

Authors:  Nina Singh; Jeffrey S Berger; Nathaniel R Smilowitz
Journal:  Am J Cardiol       Date:  2022-02-19       Impact factor: 2.778

Review 3.  Contemporary Management of Refractory Angina.

Authors:  Rebekah Lantz; Odayme Quesada; Georgia Mattingly; Timothy D Henry
Journal:  Interv Cardiol Clin       Date:  2022-07

Review 4.  Treatment of refractory angina in patients not suitable for revascularization.

Authors:  Timothy D Henry; Daniel Satran; E Marc Jolicoeur
Journal:  Nat Rev Cardiol       Date:  2013-12-24       Impact factor: 32.419

5.  A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial.

Authors:  E Marc Jolicœur; Shmuel Banai; Timothy D Henry; Marc Schwartz; Serge Doucet; Christopher J White; Elazer Edelman; Stefan Verheye
Journal:  Trials       Date:  2013-02-15       Impact factor: 2.279

6.  Reduced effects of cardiac extracorporeal shock wave therapy on angiogenesis and myocardial function recovery in patients with end-stage coronary artery and renal diseases.

Authors:  Pei-Hsun Sung; Morgan Fu; Hsin-Ju Chiang; Chi-Ruei Huang; Chi-Hsiang Chu; Mel S Lee; Hon-Kan Yip
Journal:  Biomed J       Date:  2020-10-12       Impact factor: 7.892

7.  Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+ cell therapy.

Authors:  Pei-Hsun Sung; Hsin-Ju Chiang; Yi-Chen Li; John Y Chiang; Chi-Hsiang Chu; Pei-Lin Shao; Fan-Yen Lee; Mel S Lee; Hon-Kan Yip
Journal:  Stem Cell Res Ther       Date:  2020-07-29       Impact factor: 6.832

8.  Intracoronary Injection of Autologous CD34+ Cells Improves One-Year Left Ventricular Systolic Function in Patients with Diffuse Coronary Artery Disease and Preserved Cardiac Performance-A Randomized, Open-Label, Controlled Phase II Clinical Trial.

Authors:  Pei-Hsun Sung; Yi-Chen Li; Mel S Lee; Hao-Yi Hsiao; Ming-Chun Ma; Sung-Nan Pei; Hsin-Ju Chiang; Fan-Yen Lee; Hon-Kan Yip
Journal:  J Clin Med       Date:  2020-04-07       Impact factor: 4.241

9.  The Effectiveness and Cost-Effectiveness of Spinal Cord Stimulation for Refractory Angina (RASCAL Study): A Pilot Randomized Controlled Trial.

Authors:  Sam Eldabe; Simon Thomson; Rui Duarte; Morag Brookes; Mark deBelder; Jon Raphael; Ed Davies; Rod Taylor
Journal:  Neuromodulation       Date:  2015-09-21

10.  Extracorporeal shock wave treatment attenuated left ventricular dysfunction and remodeling in mini-pig with cardiorenal syndrome.

Authors:  Jiunn-Jye Sheu; Hani E E Ali; Ben-Chung Cheng; Hsin-Ju Chiang; Pei-Hsun Sung; Kuan-Hung Chen; Chih-Chao Yang; Yen-Ta Chen; John Y Chiang; Pao-Yuan Lin; Sarah Chua; Han-Tan Chai; Sheng-Ying Chung; Cheuk-Kwan Sun; Hon-Kan Yip
Journal:  Oncotarget       Date:  2017-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.